Treatment information on these pages was kindly provided for our use by Prof Claire Harrison of Guy’s and St Thomas’ Hospital in London and MPNVoice for which MPN AA is extremely grateful.
The information which appears under FAQ and Treatments has been adapted for Australian patients by Australian haematologists – Dr Cecily Forsyth, Prof Andrew Grigg and Dr David Ross. We would like to acknowledge them for their assistance.
Information on stem cell transplants is provided via a link to the Leukaemia Foundation’s website.
Translated treatment information is available in Arabic, Chinese and Vietnamese.
The MPN AA would like to acknowledge the generosity of the accredited translators who made these translations possible.
Treatments (listed in alphabetical order)
- Anagrelide (Agrylin)
- Aspirin
- Busulfan
- Hydroxycarbamide (Hydroxyurea)
- Interferon Alpha (Pegasys)
- Momelotinib (Omjjara)
- Ruxolitinib (Jakavi)
- Stem cell transplants
- Venesection (phlebotomy)
Journal articles about MPN treatments
Clinical trials
Thanks to the remarkable increase in research interest in MPNs world wide, there are an increasing number of clinical trials available to Australian MPN patients. For information about your eligibility for a clinical trial, please ask your haematologist.
Our information page about clinical trials is HERE.
